Home /Metabolic syndrome, diabetes, and cognitive impairment in the era of combination antiretroviral therapy.
Metabolic syndrome, diabetes, and cognitive impairment in the era of combination antiretroviral therapy.
| Type: Poster |
| Title: Metabolic syndrome, diabetes, and cognitive impairment in the era of combination antiretroviral therapy. |
| Authors: McCutchan JA, Marquie-Beck J, Letendre S, Heaton R, Wolfson T, Rosario D, Alexander T, Marra C, Ances B, Grant I |
| Date: 02-08-2009 |
| Abstract:"Background: While combination ART (cART) has prolonged survival in HIV+ patients, a high prevalence of neurocognitive impairment (NCI) has persisted and cART-related metabolic syndrome has emerged as a complication. We studied the relationship of NCI and metabolic syndrome in HIV-infected participants in CHARTER, an observational study at academic clinics in the 6 US cities. |
